Identifying Host Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection (R01 Clinical Trial Not Allowed)

Department of Health and Human Services National Institutes of Health

Type

Research/project funding

Posted on

10 August 2022

Date limite d´inscription

07 December 2024

Reference Number

PAR-22-223

The purpose of this Funding Opportunity Announcement (FOA) is to support mechanistic studies on host cell death pathways and immune responses to Mycobacterium tuberculosis (Mtb) and Mtb/HIV co-infection to identify immune targets for development of host-directed therapies.
Categories: Health.

More Information

Visit Website

Type

Research/project funding

Posted on

10 August 2022

Date limite d´inscription

07 December 2024

Reference Number

PAR-22-223

Turn On Deadline Reminders

États-Unis

mtb hiv co-infection
treatment
funding opportunity announcement foa
mtb
mycobacterium tuberculosis mtb
host cell death pathway

Also Interesting

Research/Project Funding Opportunity

Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R21 Clinical Trials Not Allowed)
Research/Project Funding Opportunity

Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 - Clinical Trial Optional)
Research/Project Funding Opportunity

Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)

Identifying Host Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection (R01 Clinical Trial Not Allowed)

Research/project funding

10 August 2022

07 December 2024

PAR-22-223

Research/project funding

10 August 2022

07 December 2024

PAR-22-223

Also Interesting

Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R21 Clinical Trials Not Allowed)

Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 - Clinical Trial Optional)

Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)